Table 2.
case number | MAPT mutation | Clinical phenotype | AAO (years) | Family history | Reference |
---|---|---|---|---|---|
1 | R5H | PPA variant of FTD, CBD, ALS | 60 | Yes | Lin et al10 |
2 | L48V | PSP | 59 | No | Shi et al8 |
3 | D177V | PNFA | 57 | No | Tang et al7 |
4 | N279K | Predominant parkinsonism | 40–50 | Yes | Yang et al11 |
5 | N279K | Early parkinsonism, bvFTD developed later | 48 | Yes | Wu et al12 |
6 | H299Y | Semantic dementia | 50 | No | Che et al9 |
7 | P301L | bvFTD or PNFA | 53–59 | Yes | Shi et al8 |
8 | P301L | bvFTD | 49 | Yes | Current |
9 | G389R | bvFTD | 27 | Yes | Sun et al13 |
10 | P513 A | PNFA | 52 | Yes | Tang et al7 |
Abbreviations: AAO, age at onset; ALS, amyotrophic lateral sclerosis; bvFTD, behavioral variant frontotemporal dementia; CBD, corticobasal degeneration; FTD, frontotemporal dementia; PNFA, progressive nonfluent aphasia; PPA, primary progressive aphasia; PSP, progressive supranuclear palsy.